Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Quebec Approves Sovaldi Reimbursement


Senior Member

Status: Offline
Posts: 380
Date:
RE: Quebec Approves Sovaldi Reimbursement
Permalink  
 


Hi Isis -   I'm afraid I can't shed much light on the why? aspect of that question. Looked through the Quebec RAMQ formulary, which was updated yesterday and their Sovaldi listing is as follows:

SOFOSBUVIR: 

"in association with ribavirin and pegylated interferon alfa, for treatment of persons suffering from chronic hepatitis C genotype 1 or 4, who are not HIV-1 infected and who have never received an anti-HCV treatment; 

Authorization is granted for a maximum period of 12 weeks."

So, it would appear it's specific to tx-naive genos 1 and 4, as well as excluding the co-infected . I have no idea how much flexibility Canadian physicians have prescribing alternatively. Hopefully someone else can illuminate things for us.

Formulary Link (large pdf file)

 

 

 



__________________

66 y/o male - Geno 1b - F4 cirrhotic dx 2001 - 16 wk treatment w/ Sovaldi/Olysio/Riba - Und @ EOT+24 SVR

 



Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

Hi Olden Slow:  Just thought I'd bump this up.  

It really is exciting news that Quebec residents will now have access to Sovaldi, but are they limiting the tx to those who are tx naive, and if so, why?  



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.



Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

Excellent news!  And, tx will be provided regardless of level of fibrosis.  

What is this about treatment-naive and GT 1 and 4, though?  Are they intending to exclude tx-experienced and other GTs or am I missing something here?



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.



Senior Member

Status: Offline
Posts: 380
Date:
Permalink  
 

Priority Review by INESSS Provides Recommendation to Treat Patients with Genotypes 1 and 4 HCV Infection Regardless of Fibrosis Level

MontrealJune 2, 2014 /CNW/ -   "Gilead Sciences Canada, Inc. is pleased to announce that the Health and Social Services Ministry has placed Sovaldi® (sofosbuvir), the newest treatment for chronic hepatitis C virus (HCV) infection approved for sale in Canada, on the Liste de médicaments (effective June 2, 2014).  With this listing, Quebec becomes the first Canadian province to provide access to Sovaldi for treatment-naïve patients with genotypes 1 and 4 HCV infection regardless of liver severity."

Full Article

CAPAHC Article

 



__________________

66 y/o male - Geno 1b - F4 cirrhotic dx 2001 - 16 wk treatment w/ Sovaldi/Olysio/Riba - Und @ EOT+24 SVR

 

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.